Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T40556 | Target Info | |||
Target Name | Bromodomain-containing protein 4 (BRD4) | ||||
Synonyms | Protein HUNK1; HUNK1 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | BRD4 | ||||
Biochemical Class | Bromodomain | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Bromosporine | Ligand Info | |||
Canonical SMILES | CCOC(=O)NC1=CC(=NN2C1=NN=C2C)C3=CC(=C(C=C3)C)NS(=O)(=O)C | ||||
InChI | 1S/C17H20N6O4S/c1-5-27-17(24)18-15-9-14(21-23-11(3)19-20-16(15)23)12-7-6-10(2)13(8-12)22-28(4,25)26/h6-9,22H,5H2,1-4H3,(H,18,24) | ||||
InChIKey | UYBRROMMFMPJAN-UHFFFAOYSA-N | ||||
PubChem Compound ID | 72943187 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6V0U Crystal structure of the first bromodomain (BD1) of human BRD4 bound to bromosporine | ||||||
Method | X-ray diffraction | Resolution | 1.40 Å | Mutation | No | [1] |
PDB Sequence |
MNPPPPETSN
52 PNKPKRQTNQ62 LQYLLRVVLK72 TLWKHQFAWP82 FQQPVDAVKL92 NLPDYYKIIK 102 TPMDMGTIKK112 RLENNYYWNA122 QECIQDFNTM132 FTNCYIYNKP142 GDDIVLMAEA 152 LEKLFLQKIN162 ELPTEE
|
|||||
|
||||||
PDB ID: 5IGK Crystal structure of the first bromodomain of human BRD4 in complex with bromosporine (BSP) | ||||||
Method | X-ray diffraction | Resolution | 1.70 Å | Mutation | No | [2] |
PDB Sequence |
SMNPPPPETS
51 NPNKPKRQTN61 QLQYLLRVVL71 KTLWKHQFAW81 PFQQPVDAVK91 LNLPDYYKII 101 KTPMDMGTIK111 KRLENNYYWN121 AQECIQDFNT131 MFTNCYIYNK141 PGDDIVLMAE 151 ALEKLFLQKI161 NELPTEE
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structural Basis of Inhibitor Selectivity in the BRD7/9 Subfamily of Bromodomains. J Med Chem. 2020 Mar 26;63(6):3227-3237. | ||||
REF 2 | Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia. Sci Adv. 2016 Oct 12;2(10):e1600760. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.